Associations of discomfort intolerance, discomfort avoidance, and cannabis and alcohol use among persons with chronic pain receiving prescription buprenorphine for opioid use disorder
- 25 October 2024
- journal article
- research article
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 265, 112472
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Institute on Drug Abuse (R01DA045695)
This publication has 40 references indexed in Scilit:
- Use of Medication for Opioid Use Disorder Among Adults With Past-Year Opioid Use Disorder in the US, 2021JAMA Network Open, 2023
- Trends in Buprenorphine Initiation and Retention in the United States, 2016-2022JAMA, 2023
- Racial and Ethnic Disparities in Buprenorphine Treatment Duration in the USJAMA Psychiatry, 2023
- Cost-effectiveness of Treatments for Opioid Use DisorderJAMA Psychiatry, 2021
- Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid DependenceJAMA Psychiatry, 2021
- Buprenorphine–cannabis interaction in patients undergoing opioid maintenance therapyEuropean Archives of Psychiatry and Clinical Neuroscience, 2020
- Chronic Pain and DepressionAmong Primary Care Patients Treated with BuprenorphineJournal of General Internal Medicine, 2015
- Variation in Use of Buprenorphine and Methadone Treatment by Racial, Ethnic, and Income Characteristics of Residential Social Areas in New York CityThe Journal of Behavioral Health Services & Research, 2013
- The Fear-Avoidance Model of Musculoskeletal Pain: Current State of Scientific EvidenceJournal of Behavioral Medicine, 2006
- A Brief Measure for Assessing Generalized Anxiety DisorderArchives of internal medicine (1960), 2006